ALEXIS GEPPNER: Open Payments
NPI 1699056457 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 30 payments from 12 companies in 2025. Trend: 2023 $4,266 · 2024 $3,583 · 2025 $1,200
Food & beverage: $1,200
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 7 | $360 |
| Incyte Corporation | 4 | $191 |
| ABBVIE INC. | 3 | $185 |
| GlaxoSmithKline, LLC. | 4 | $108 |
| SOBI, INC | 3 | $93 |
| Astellas Pharma US Inc | 2 | $63 |
| Celgene Corporation | 2 | $49 |
| PFIZER INC. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Rigel Pharmaceuticals, Inc. | 1 | $32 |
Products named: JAKAFI, OJJAARA, Vonjo, EPKINLY, BOSULIF, Xospata, CALQUENCE, TAVALISSE.
Industry payments across TX — which companies pay providers there.
